Agilent's Q2: Solid Company With Good Growth Prospects
Wall Street Cheat Sheet submits: Instrumentation and measurement company Agilent (NYSE: A) reported second-quarter earnings per share of $0.43 after the bell Monday, beating analysts' estimates by $0.2 per share (see transcript). The company reported earnings per share of $0.13 for the year-ago quarter. Revenue came in at $1.27 billion, up over 16 percent from one year ago, on orders of $1.35 billion, a YOY increase of 31 percent. This is another profitable quarter for the company. In the prior quarter, revenues increased 4 percent and net income increased 23 percent. The company had a $100 million net loss in 2009 for a negative $0.29 per share.Complete Story » seekingalpha.com |
BUYINS.NET Updates Cord Blood America SqueezeTrigger Report (GlobeNewswire)
NEWPORT BEACH, Calif. -- BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has updated coverage on Cord Blood America after releasing the latest short sale data through June 8, 2010. us.rd.yahoo.com |
New Way to Regenerate Tissue
Scientists say they got muscle tissue in mice to regenerate, essentially re-awakening an ability that had been lost over evolutionary time. It is hoped that the approach will one day offer a way to make fresh tissue and help repair damaged organs. online.wsj.com |
Five Potential Small Cap Biotech Bargains
Rockford Coscia submits:Today I wanted to talk about a measure of stock value that is often used in the equity research groups but is used only sparingly with amateur traders: enterprise value/revenues. For those who haven't heard of this measure of stock value let me provide a quick introduction.Complete Story » seekingalpha.com |
Quest Diagnostics Increases Share Repurchase Authority By $250 Million
[PR Newswire] - Quest Diagnostics Incorporated , the world's leading provider of diagnostic testing, information and services, announced that its Board of Directors increased the company's share repurchase authorization by $250 million. us.rd.yahoo.com |